MK-801 attenuates the methamphetamine induced decreased in tryptophan hydroxylase activity.
Gibb
J W
JW
Department of Pharmacology and Toxicology, University of Utah, Salt Lake City 84108.
Johnson
M
M
Hanson
G R
GR
D015104:3,4-Methylenedioxyamphetamine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants; D001921:Brain / Q000187:drug effects*; D003342:Corpus Striatum / Q000187:drug effects; D003986:Dibenzocycloheptenes / Q000494:pharmacology*; D016291:Dizocilpine Maleate; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology*; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D009410:Nerve Degeneration / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D017470:Receptors, Glutamate; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter / Q000187:drug effects*; D011985:Receptors, Serotonin / Q000187:drug effects*; D014365:Tryptophan Hydroxylase / Q000037:antagonists & inhibitors*
D000927:Anticonvulsants; D003986:Dibenzocycloheptenes; D017470:Receptors, Glutamate; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter; D011985:Receptors, Serotonin; D008694:Methamphetamine; D015104:3,4-Methylenedioxyamphetamine; D016291:Dizocilpine Maleate; D014365:Tryptophan Hydroxylase; D018817:N-Methyl-3,4-methylenedioxyamphetamine